News
CDC staffers are voicing frustration over RFK Jr.’s past vaccine comments, following Friday’s shooting at the agency’s ...
Plus more pharma news from the Pharmalittle newsletter.
The cancer vaccine did not significantly boost progression-free survival (PFS), but IO Biotech plans to seek out its approval anyway.
The system for compensating people injured by vaccines needs significant reform. But the health secretary could alter it in ...
IO Biotech’s cancer vaccine has “narrowly” failed to beat Merck's blockbuster oncology drug Keytruda in a phase 3 melanoma ...
3d
MedPage Today on MSNDid FDA Pick the Wrong COVID Vaccine Strain Last Season? | MedPage Today
In Danes over age 65, the vaccine effectiveness of the JN.1-based mRNA boosters reached 70-85% against COVID-related ...
IO Biotech said on Monday its experimental combination cancer vaccine helped slow the disease's progression in a late-stage ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results